Trial Profile
Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Nov 2015 New trial record